Arsenic levels higher in patients with nonmelanoma skin cancers

Arsenic levels higher in patients with nonmelanoma skin cancers

(HealthDay)—Certain arsenic species levels are higher among patients with nonmelanoma skin cancer (NMSC), according to a study published online Aug. 16 in the Journal of Dermatology.

Tae-Hoon Kim, from Dong-A University in Busan, South Korea, and colleagues compared the creatinine-adjusted urinary concentration of arsenic in NMSC patients and community controls to validate the contribution of each arsenic species to NMSC. Data were included for 124 biopsy-proven NMSC cases and 125 age- and sex-matched community controls, drinking tap water with a low-level arsenic concentration.

The researchers observed significantly higher levels of total inorganic arsenic, trivalent and pentavalent arsenic, and monomethylarsonic acid for the NMSC group than controls. The NMSC group had lower total arsenic, organic arsenic, and dimethylarsonic acid levels.

"We suggest that species, trivalent arsenic, and pentavalent arsenic may influence the prevalence of NMSC, in spite of these levels being lower than the Agency for Toxic Substances and Disease Registry-recommended standard or the levels reported by other highly contaminated areas and neighboring countries in East Asia," the authors write. "Furthermore, it also suggests that total level cannot represent the risk of NMSC."

More information: Abstract
Full Text (subscription or payment may be required)

Copyright © 2017 HealthDay. All rights reserved.

Citation: Arsenic levels higher in patients with nonmelanoma skin cancers (2017, August 22) retrieved 14 June 2024 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Arsenic metabolism linked to development of type 1 diabetes


Feedback to editors